Background: In low-and middle-income countries (LMICs), inconsistent or delayed management of fever contributes to poor outcomes among pediatric patients with cancer. We hypothesized that standardizing practice with a clinical algorithm adapted to local resources would improve outcomes. Therefore, we developed a resource-specific algorithm for fever management in Davao City, Philippines. The primary objective of this study was to evaluate adherence to the algorithm.
INTRODUCTION
Infectious complications are major contributors to mortality among pediatric patients treated for cancer in low-and middle-income countries (LMICs). 1,2 Specifically, inconsistent or delayed management of infections is a driver of poor outcomes. 1, [3] [4] [5] [6] In high-income countries (HICs), guidelines and algorithms have reduced management inconsistencies and expedited appropriate care. [7] [8] [9] Fever-management algorithms for oncology patients are commonly used in these settings.
Abbreviations: ESBL, extended-spectrum beta-lactamase; HIC, high-income countries; LMIC, low-and middle-income country; PCC, pediatric cancer center Although the limitations on staffing and specialist support in LMICs might suggest that such algorithms would be particularly useful in those countries, the differences in health delivery systems and resource constraints preclude the use of identical guidelines in all LMICs. Nevertheless, practical recommendations are required for these countries, where an estimated 80% of all children with cancer live. 10 Accordingly, the International Society for Pediatric Oncology recommends that LMIC centers treating patients with cancer develop local fever-management protocols, although it does not endorse specific therapeutic or design approaches. 1 The Sociedad Latinoamericana de Infectología Pediátrica has published a consensus guideline prepared in collaboration with healthcare workers in LMICs, but this guideline is still based on experience in HICs. 3 The primary objective of our study was to measure healthcare provider adherence to a resource-specific algorithm for managing febrile pediatric oncology patients in Davao City in the Philippines, which is defined by the World Bank as a lower middle-income country.
METHODS

Study setting
The Southern Philippines Medical Center (SPMC) is a tertiary referral institution serving Davao City and southern portions of Mindanao Chemotherapy drugs such as prednisone, vincristine, methotrexate, doxorubicin, L-asparaginase, mercaptopurine, and cyclophosphamide are given over a period of 2.5 years. During the course of treatment, patients are instructed to proceed directly to the PCC should they develop fever or symptoms suggestive of infection; however, some patients are admitted from the emergency department or outpatient clinic.
Algorithm development
An algorithm to manage fever in pediatric oncology patients was developed and piloted over a 13-month period starting in February 2013.
The algorithm was created using a three-step process: (1) information gathering, (2) algorithm and consensus building, and (3) algorithm validation and pilot implementation. A combined SPMC/St. Jude research team first conducted semistructured interviews with medical personnel, reviewed medical records, observed care practices, and verified the pricing and availability of ancillary testing and antimicrobials. This investigation revealed that attending physicians, residents, and nursing team members had different definitions of fever, different perceptions of its urgency, and different approaches to managing it. For example, blood cultures were not routinely obtained, and antibiotics were not selected in a uniform manner because of supply problems, cost concerns, and knowledge limitations. To address these discrepancies, our team generated an algorithm by adapting published guidelines to local resources. [3] [4] [5] [6] HIC clinical criteria were modified to devise a riskstratification rubric to identify patients at high risk for serious infection on admission. [11] [12] [13] [14] [15] Fig. S1 ).
Training in the revised algorithm
In March 2014, team members conducted mandatory on-site training sessions on the updated algorithm and blood-culture collection practices for all current healthcare providers of the PCC. Lectures were recorded to standardize the training for each group of rotating residents and for retraining purposes. The algorithm was posted in the nurses' station, treatment rooms, outpatient clinic, and emergency department.
Monitoring adherence
A prospective study of algorithm adherence began in September 2014.
All patients aged 18 years or younger with cancer diagnoses who received chemotherapy within 3 months of admission and were admitted with fever (defined as an axillary temperature > 37.7 • C measured on one occasion or an axillary temperature ≥37.4 • C measured on two occasions 1 hr apart) qualified for inclusion. Patients who were afebrile on presentation but developed fever within 48 hr of admission were also included. 7 The protocol was approved by the Ethics Committee of the SPMC and the St. Jude Institutional Review Board. The requirement for informed consent was waived, as the intervention fell within the scope of ongoing quality improvement.
Outcomes measured
Sociodemographic information, clinical and laboratory details of the presenting illness, and oncologic history were obtained for each patient at enrollment. The primary outcome measured was algorithm adherence, defined as the completion of any mandatory step of the algorithm. Secondary objectives included describing the types of deviation and reasons for deviation (nonadherence), along with the differences in the length of hospital stay, incidence of admission to the intensive care unit (ICU), and mortality between patients whose fever was managed according to the algorithm and those whose fever management did not follow the algorithm. The study focused on the first 7 days of hospitalization after fever onset, because the clinical course is too variable thereafter to be amenable to algorithmic management.
Patients were identified for inclusion during morning rounds, and algorithm adherence was monitored prospectively by a nurse on the infection prevention team who was involved in developing and implementing the algorithm. When a deviation was noted, this individual approached practitioners to ascertain the reasons why the deviation occurred.
Statistical analysis
The study outcomes, along with demographic and clinical features of the study population, were summarized by descriptive statistics (i.e., medians and ranges for continuous data and frequency counts and proportions for categorical data). Chi-squared or Fisher's exact tests 
RESULTS
Patients
Between September 1, 2014 and September 30, 2015, 141 febrile episodes were accrued representing 93 individual patients; Table 1 presents their sociodemographic and clinical characteristics. Of the patient episodes, 89% qualified for national insurance subsidization of up to 50% of hospital expenses based on the families' annual income.
We found no association between the delay in hospital presenta- 
Algorithm adherence and deviation
Supplementary Figure S1 shows the algorithm for adherence evalua- 
of cases (seven of 34) in which blood culture was missed (Supplementary Table S1 ). The number of patients with algorithm nonadherence dropped markedly on days 1 and 2, with a slight increase on day 3.
Because fewer patients remained hospitalized beyond day 4, the subsequent decrease in episodes with nonadherence reflects the diminishing number of patients at risk (Supplementary Table S2 ). Figure 1A shows the proportion of daily deviations of each type.
As certain orders, such as those for radiology and laboratory tests, are routine only on day 0, the relative proportions of deviation represented by other order types increase on subsequent days. Failure to appropriately treat high-risk patients constituted 13% of deviations on day 0 and 29% of deviations on day 1. Missed doses of ordered antimicrobials accounted for 21-50% of deviations on days 1 through 6 of hospitalization. Figure 1B shows the reasons provided for nonadherence.
The frequencies of presenting symptoms for all episodes are listed in Supplementary Table S3 , and selected clinical outcomes are presented in Table 2 . Patients defervesced within 48 hr of admission in 48% of episodes with documented fever after admission (67 of 139),
and ICU admission and mortality were infrequent. Organisms isolated from bacteremias or from alternate sites are listed in Table 3 . Bacteria were isolated from 12 blood cultures. Two isolates testing positive for Staphylococcus hominis (17% of positive blood cultures) were considered to represent contaminants, and one-third-a Bacillus species in a patient with abdominal symptoms-was of uncertain pathogenicity.
Escherichia coli was isolated from three blood cultures and from a single urine specimen, with two of the three blood isolates and the single urine isolate being extended-spectrum beta-lactamase (ESBL) producing variants.
Pneumonia was commonly reported but was not associated with poor outcomes. The presence of mucositis grade III on admission (P = 0.035), isolation of a pathogen (P = 0.005), diagnosis of a Early discharge, discharge on a day other than indicated by the algorithm; nonalgorithm antibiotics, antibiotics other than those stipulated in the algorithm were prescribed; broad spectrum, a patient categorized as low risk received antibiotics indicated for high-risk patients; blood culture, blood culture was not performed; missed dose, at least one dose of an ordered antimicrobial agent was not administered; other lab, an indicated laboratory test other than blood culture was not performed; stratification, a patient with high-risk characteristics was treated as a low-risk patient; vancomycin, a clinician judged that a patient met criteria for administration of vancomycin, but this was not administered. (B) Reasons for deviation are provided as a percentage of the total reasons for deviation provided on the given day. The trend line indicates the number of reasons for deviation seen each day. Reasons for deviation: nosocomial, provider treating for nosocomial infection; knowledge, provider knowledge deficiency; financial, inability to afford medicines or laboratory tests; infectious source, provider treating for suspected infectious source nonrespiratory infectious focus (P < 0.001), and use of a broadspectrum antibiotic on any day (P < 0.0001) were all associated with significantly prolonged hospitalization on univariate analysis (Supplementary Table S4 ). Episodes with deviation on day 1 resulted in longer hospitalization than did episodes with no deviation on day 1 (10 vs.
TA B L E 2 Clinical outcomes
8 days; P = 0.004). Among those episodes with deviation on day 0, risk-stratification errors were associated with hospitalization that
TA B L E 3 Frequency of pathogen isolation
Pathogen Site Frequency
Acinetobacter jeunii Blood 1
Bacillus species Blood 1
Chryseobacterium indologenes Blood 1
Escherichia coli Blood 3
Klebsiella pneumoniae Blood 1
Pseudomonas aeruginosa Blood 2
Staphylococcus hominis Blood 2
Streptococcus pneumoniae Blood 1
Escherichia coli Urine 1
Ascaris lumbricoides Stool 1 (Table 4 ).
Entamoeba histolytica
DISCUSSION
Our experience reveals that even locally created algorithms face barriers to implementation. Some deviations from the algorithm, for example, risk-stratification errors or missed antibiotic doses, were associated with prolonged hospitalization, as was inability to afford an indicated service. Identifying and averting key deviations may improve hospital resource utilization and the quality of care delivered in PCCs in LMICs, signaling the potential of fever algorithms as qualityimprovement tools.
When we excluded predefined minor deviations (i.e., nonindicated use of broad-spectrum antibiotics and failure to perform urinalysis) from our analysis, febrile episodes with major deviations increased overall mortality, but this was not statistically significant (6% vs. 0%; P = 0.075). Our findings are consistent with reports that clinical practice guidelines for febrile neutropenia are associated with reduced ICU admissions, septic shock, and mortality. 8, 16 Centers have reported improved outcomes, including decreased mortality, after introducing best-practice bundles. 17, 18 Centers in LMICs may have insufficient resources to address all causes of deviation, particularly inability to afford services. Nevertheless, cancer-directed therapy should not be 22, 24 No patient developed pulmonary or disseminated fungal infection, and none received antifungal therapy more aggressive than fluconazole. This may reflect the lower intensity of anticancer treatment relative to that in HICs, resulting in less prolonged neutropenia; however, the evaluation is confounded by the limited access to diagnostic studies beyond culture. As access to more aggressive cancer treatments, antimicrobials, diagnostic studies, and central venous line placement increases, the burden of fungal infection in pediatric oncology patients in LMICs will merit further investigation.
TA B L E 4 Multivariate regression model results for investigation of predictors of duration of hospitalization
Although our study was designed to mitigate threats to data collection and validity, some limitations were unavoidable. The prospective design enabled us to obtain reasons for deviation; however, because those responses were not anonymous, they were subject to provider recall bias. The low number of complications precluded our demonstrating associations between deviation and mortality or ICU admission. Having anticipated this, we used the length of hospitalization as a proxy marker for clinical status by assuming that all patients in the study remained hospitalized for reasons related to febrile neutropenia. This assumption may be invalid. As we could not discern when a patient would have been discharged had they not needed chemotherapy, and because receipt of chemotherapy was not an explicitly collected variable, our analysis did not attempt to account for stays due to chemotherapy. The greatest limitation, however, may be our inability to quantify changes in outcomes between the pre-and postalgorithm eras because of the lack of reliable baseline data. As developing a fevermanagement algorithm was deemed part of routine practice improvement, deferring its implementation to collect baseline data was judged unethical. We believe, however, that the existing literature is sufficient to establish the benefits of guideline use. 
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